Cargando…

Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma

Detalles Bibliográficos
Autores principales: Yan, Wenqiang, Fan, Huishou, Xu, Jingyu, Liu, Jiahui, Li, Lingna, Du, Chenxing, Deng, Shuhui, Sui, Weiwei, Xu, Yan, Zou, Dehui, Qiu, Lugui, An, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344481/
https://www.ncbi.nlm.nih.gov/pubmed/37306432
http://dx.doi.org/10.1097/CM9.0000000000002735
_version_ 1785072876319145984
author Yan, Wenqiang
Fan, Huishou
Xu, Jingyu
Liu, Jiahui
Li, Lingna
Du, Chenxing
Deng, Shuhui
Sui, Weiwei
Xu, Yan
Zou, Dehui
Qiu, Lugui
An, Gang
author_facet Yan, Wenqiang
Fan, Huishou
Xu, Jingyu
Liu, Jiahui
Li, Lingna
Du, Chenxing
Deng, Shuhui
Sui, Weiwei
Xu, Yan
Zou, Dehui
Qiu, Lugui
An, Gang
author_sort Yan, Wenqiang
collection PubMed
description
format Online
Article
Text
id pubmed-10344481
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103444812023-07-20 Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma Yan, Wenqiang Fan, Huishou Xu, Jingyu Liu, Jiahui Li, Lingna Du, Chenxing Deng, Shuhui Sui, Weiwei Xu, Yan Zou, Dehui Qiu, Lugui An, Gang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-06-09 2023-07-20 /pmc/articles/PMC10344481/ /pubmed/37306432 http://dx.doi.org/10.1097/CM9.0000000000002735 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Yan, Wenqiang
Fan, Huishou
Xu, Jingyu
Liu, Jiahui
Li, Lingna
Du, Chenxing
Deng, Shuhui
Sui, Weiwei
Xu, Yan
Zou, Dehui
Qiu, Lugui
An, Gang
Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title_full Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title_fullStr Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title_full_unstemmed Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title_short Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
title_sort prognostic value of the second revision of the international staging system (r2-iss) in a real-world cohort of patients with newly-diagnosed multiple myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344481/
https://www.ncbi.nlm.nih.gov/pubmed/37306432
http://dx.doi.org/10.1097/CM9.0000000000002735
work_keys_str_mv AT yanwenqiang prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT fanhuishou prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT xujingyu prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT liujiahui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT lilingna prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT duchenxing prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT dengshuhui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT suiweiwei prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT xuyan prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT zoudehui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT qiulugui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma
AT angang prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma